Mira Pharmaceuticals, Inc. SEC filings MIRA
Mira Pharmaceuticals, Inc. has 198 filings in SEC EDGAR's recent list, going back to Jun 29, 2022. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Filing | Jul 29, 2025 | — |
| EFFECT | Filing | Aug 16, 2024 | — |
| CORRESP | Letter to the SEC | Aug 15, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| EFFECT | Filing | Dec 27, 2023 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2023 | — |
| EFFECT | Filing | Aug 2, 2023 | — |
| CERT | Filing | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 31, 2023 | — |
| 8-A12B | Filing | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2023 | — |
| DRSLTR | Filing | Jun 8, 2023 | — |
| DRS/A | Filing | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 30, 2023 | — |
| DRS/A | Filing | May 2, 2023 | — |
| D | Filing | Aug 1, 2022 | — |
| D | Filing | Aug 1, 2022 | — |
| DRS | Filing | Jun 29, 2022 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRA (Nasdaq)
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1904286
- Former names
- Mira1a Therapeutics, Inc. (until May 2, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.